NASDAQ
Recursion Pharmaceuticals, Inc. (RXRX) has had 28 insider transactions recently, with net insider activity of -$515K (net selling). The most active insider is Khan Najat (Director, officer: ceo and president).
Total Transactions
28
7 buys /21 sells
Shares Acquired
228,170
Transactions: 7•Avg: 32,595.71
Shares Disposed
743,199
Transactions: 21•Avg: 35,390.43
Net Activity
-515,029
Net Selling•Ratio: 33.33%
Q2 2026(Current) | 228,170 | 743,199 | -515,029 | 33.33% |
Q1 2026 | 2,977,041 | 1,255,644 | +1,721,397 | 53.57% |
Q4 2025 | 679,678 | 1,284,996 | -605,318 | 43.48% |
Q3 2025 | 866,414 | 1,709,459 | -843,045 | 44.44% |
Q2 2025 | 401,296 | 85,529 | +315,767 | 320.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q2 2026
Acquired vs Disposed Shares
Net Distribution: 515,029 shares•Acquired/Disposed Ratio: 33.33%
Net Activity | |||||
|---|---|---|---|---|---|
KN Khan Najat | Director, officer: ceo and president | 11 | 1,958,668 | 281,218 | +1,677,450 |
BB Borgeson Blake | Director | 7 | 0 | 920,000 | -920,000 |
GC Gibson Christopher | Director | 53 | 690,346 | 1,400,840 | -710,494 |
HD Hallett David | Officer: chief scientific officer | 11 | 526,318 | 1,011,576 | -485,258 |
TBR Taylor Ben R | Officer: chief financial officer | 13 | 470,533 | 167,430 | +303,103 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2026-06-05 | Director | Sale | 40,000 | $0 | $0 | 4,263,334 | |
2026-06-05 | Director | Purchase | 40,000 | $0 | $0 | 923,735 | |
2026-06-05 | Director | Sale | 40,000 | $3.62 | $144,800 | 883,735 | |
2026-06-05 | Director, officer: ceo and president | Sale | 23,588 | $3.58 | $84,459.19 | 2,175,796 | |
2026-06-03 | Director | Sale | 4,386 | $3.54 | $15,526.44 | 43,171 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
GC Gibson Christopher | Director | Jun 5, 2026 | |
GC Gibson Christopher | Director | Jun 5, 2026 | |
GC Gibson Christopher | Director | Jun 5, 2026 | |
KN Khan Najat | Director, officer: ceo and president | Jun 5, 2026 | |
BN Bumpus Namandje | Director | Jun 4, 2026 |
Net change in shares shown on right
No price data available for this timeframe.